Fuda Cancer Hospital
Metastases in the liver treatment cost in China typically runs from $6,200 to $10,500 for chemoembolization of the liver. Surgical options like liver resection range from $18,500 to $38,500. Total expenses depend on the cancer stage, chosen technology, and hospital tier. Patients often save 40-60% compared to the US. Top cities for these advanced oncological procedures include Guangzhou and Beijing.
Typical Metastases In The Liver Treatment Costs In China
Bookimed Expert Insight: Patients with advanced or multi-focal metastases should prioritize clinics offering specialized minimally invasive technologies. Fuda Cancer Hospital in Guangzhou is a leading choice for these complex cases. They utilize JCI-accredited protocols for NanoKnife and cryosurgery to treat tumors in difficult locations. This approach is ideal for patients who are not candidates for traditional open surgery. The facility has successfully treated over 30,000 international patients using these targeted vascular interventional therapies.
| China | Turkey | Austria | |
| Removal of liver cancer | from $21,500 | from $10,800 | from $40,000 |
| Radiofrequency ablation of the liver | from $5,500 | from $3,500 | from $12,000 |
| Liver resection | from $18,500 | from $11,700 | from $35,000 |
| Chemoembolization of the liver | from $6,200 | from $7,500 | from $16,000 |
| Chemotherapy for liver cancer | from $3,500 | from $1,800 | - |
Dr. Liu Shi Xin is the Vice Chairman of the Radiation Oncology Branch of the Chinese Medical Association. He serves as the Discipline Leader of the Oncology Center at Xiamen Humanity Hospital. Dr. Liu specializes in precision radiotherapy for thoracic and abdominal cancers. He is a recipient of the State Council Special Government Allowance for his medical contributions.
Dr. Niu Lizhi is the President and chief surgeon at Fuda Cancer Hospital in Guangzhou. He has performed nearly 10,000 cryosurgeries and 500 NanoKnife procedures. Dr. Niu specializes in minimally invasive oncology for lung, pancreatic, and liver cancers. He treats patients ranging from early childhood through age 94.
Chinese oncology centers provide advanced Western treatments for liver metastases, focusing on minimally invasive ablation, catheter-directed therapies, and surgical resection. Accredited facilities like Fuda Cancer Hospital utilize JCI-standard protocols. These include NanoKnife and cryosurgery to target tumors while preserving healthy liver tissue.
Bookimed Expert Insight: Data from Fuda Cancer Hospital reveals a specialized focus on late-stage cases often deemed inoperable elsewhere. While many centers prioritize standard resection, Fuda utilizes a high volume of non-thermal NanoKnife procedures. This approach is specifically effective for metastases located near major blood vessels where heat-based ablation or surgery risks internal damage. This specialization has attracted patients from over 100 countries seeking alternatives for complex tumor locations.
Patient Consensus: Patients note that leading centers often propose aggressive multidisciplinary sequencing, moving quickly from systemic therapy to local interventions. Many emphasize the importance of bringing original biopsy reports and genomic results to avoid repeat testing delays.
China offers advanced non-invasive radiation options like Proton Beam Therapy through a rapidly expanding network of specialized oncology centers. Facilities in Shanghai and Guangzhou utilize high-precision particle therapy to treat complex liver metastases. These institutions maintain international standards with Joint Commission International accreditations and advanced delivery systems.
Bookimed Expert Insight: While Proton Beam Therapy is a major draw, high-volume centers like Fuda Cancer Hospital often prioritize a combination of NanoKnife and vascular interventional therapy for liver metastases. Data shows these minimally invasive techniques are frequently selected over radiation for late-stage cases. Patients should verify if a facility's 400-bed capacity includes dedicated space for international oncology recovery.
Patient Consensus: Patients note that while newer technology is attractive, doctors often recommend Stereotactic Body Radiation Therapy (SBRT) for liver lesions. They emphasize bringing complete pathology reports to ensure the tumor location actually qualifies for proton treatment.
China integrates Traditional Chinese Medicine (TCM) for liver metastases as a supportive therapy alongside Western protocols. Chinese oncology programs follow national guidelines to combine TCM with chemotherapy, immunotherapy, and interventional procedures. These integrative methods aim to optimize tolerance, support liver function, and manage treatment side effects.
Bookimed Expert Insight: While many Chinese centers provide integrative care, hospitals with JCI accreditation like Fuda Cancer Hospital emphasize specialized technologies. They utilize cryosurgery and NanoKnife for liver lesions alongside supportive interventional therapies. Leading oncologists in China, such as Professor Liu Shi Xin at Xiamen Humanity Hospital, participate in both the Chinese Medical Association and the Chinese Anti-Cancer Association. This ensures that TCM integration remains strictly under the supervision of qualified Western-trained medical experts.
Patient Consensus: Patients note that TCM helps them feel less destroyed by improving appetite and energy levels during chemo. They emphasize that measurable results come from Western medicine, while herbs serve as a practical way to manage day-to-day comfort.